Cargando…

Dual Antiplatelet Therapy after Noncardioembolic Ischemic Stroke or Transient Ischemic Attack: Pros and Cons

Dual antiplatelet therapy simultaneously blocks different platelet activation pathways and might thus be more potent at inhibiting platelet activation and more effective at reducing major ischemic vascular events compared to antiplatelet monotherapy. Aspirin plus clopidogrel dual therapy is now the...

Descripción completa

Detalles Bibliográficos
Autor principal:	Hong, Keun-Sik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Neurological Association 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101094/ https://www.ncbi.nlm.nih.gov/pubmed/25045370 http://dx.doi.org/10.3988/jcn.2014.10.3.189

Ejemplares similares

Balancing Benefits and Risks of Long-Term Antiplatelet Therapy in Noncardioembolic Transient Ischemic Attack or Stroke
por: Hilkens, Nina A., et al.
Publicado: (2021)

Long-Term Antiplatelet Mono- and Dual Therapies After Ischemic Stroke or Transient Ischemic Attack: Network Meta-Analysis
por: Xie, Wuxiang, et al.
Publicado: (2015)

Dual vs. mono antiplatelet therapy for acute ischemic stroke or transient ischemic attack with evidence of large artery atherosclerosis
por: Lin, Chun-Jen, et al.
Publicado: (2022)

Dual antiplatelet therapy reduced stroke risk in transient ischemic attack with positive diffusion weighted imaging
por: Pei, Lu-lu, et al.
Publicado: (2020)

Stopping “transient ischemic attacks” by antiplatelet withdrawal
por: Palaiodimou, Lina, et al.
Publicado: (2021)

Antiplatelet Therapy in the Secondary Prevention of Non-cardioembolic Ischemic Stroke and Transient Ischemic Attack: A Mini-Review
por: Vališ, Martin, et al.
Publicado: (2021)

Antiplatelet Therapy After Noncardioembolic Stroke: An Individual Patient Data Network Meta-Analysis
por: Greving, Jacoba P., et al.
Publicado: (2019)

Transient ischemic attacks: predictability of future ischemic stroke or transient ischemic attack events
por: Gupta, Harsh V, et al.
Publicado: (2014)

Costs and outcomes of noncardioembolic ischemic stroke in a managed care population
por: Engel-Nitz, Nicole M, et al.
Publicado: (2010)

The role of CYP2C19 genotyping to guide antiplatelet therapy following ischemic stroke or transient ischemic attack
por: McDermott, John H, et al.
Publicado: (2022)

Antiplatelet regimens after ischemic stroke or transient ischemic attack: a systematic review and updated network meta-analysis
por: Jung, Seung Jin, et al.
Publicado: (2022)

Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasms
por: De Stefano, Valerio, et al.
Publicado: (2018)

Cardiac Imaging After Ischemic Stroke or Transient Ischemic Attack
por: Camen, S., et al.
Publicado: (2020)

Dual versus mono antiplatelet therapy for acute non- cardio embolic ischemic stroke or transient ischemic attack, an efficacy and safety analysis - updated meta-analysis
por: Albay, Christessa Emille Que, et al.
Publicado: (2020)

Personalized antiplatelet therapy guided by clopidogrel pharmacogenomics in acute ischemic stroke and transient ischemic attack: A prospective, randomized controlled trial
por: Zhang, Xiaoguang, et al.
Publicado: (2023)

Antiplatelet regimens for Asian patients with ischemic stroke or transient ischemic attack: a systematic review and network meta-analysis
por: Jung, Seung Jin, et al.
Publicado: (2021)

Antiplatelet Treatment After Transient Ischemic Attack and Ischemic Stroke in Patients With Cerebral Microbleeds in 2 Large Cohorts and an Updated Systematic Review
por: Lau, Kui Kai, et al.
Publicado: (2018)

2022 Update of the Korean Clinical Practice Guidelines for Stroke: Antithrombotic Therapy for Patients with Acute Ischemic Stroke or Transient Ischemic Attack
por: Park, Hong-Kyun, et al.
Publicado: (2022)

Acute dual antiplatelet therapy for minor ischaemic stroke or transient ischaemic attack
por: Wang, Yongjun, et al.
Publicado: (2019)

Analysis of Prescriptions for Dual Antiplatelet Therapy After Acute Ischemic Stroke
por: Xian, Ying, et al.
Publicado: (2022)

Retraction Note: Dual versus mono antiplatelet therapy for acute non- cardio embolic ischemic stroke or transient ischemic attack, an efficacy and safety analysis - updated meta-analysis
por: Albay, Christessa Emille Que, et al.
Publicado: (2020)

Antiplatelet drugs for secondary prevention in patients with ischemic stroke or transient ischemic attack: a systematic review and network meta-analysis
por: Del Giovane, Cinzia, et al.
Publicado: (2021)

Statin Prescription Adhered to Guidelines for Patients Hospitalized due to Acute Ischemic Stroke or Transient Ischemic Attack
por: Hong, Keun-Sik, et al.
Publicado: (2013)

Difference in the Prognostic Significance of N-Terminal Pro-B-Type Natriuretic Peptide between Cardioembolic and Noncardioembolic Ischemic Strokes
por: Lee, Seung-Jae, et al.
Publicado: (2015)

Hemoglobin Concentration and Clinical Outcomes After Acute Ischemic Stroke or Transient Ischemic Attack
por: Zhang, Runhua, et al.
Publicado: (2021)

Predictors for Returning to Paid Work after Transient Ischemic Attack and Minor Ischemic Stroke
por: Wicht, Corentin A., et al.
Publicado: (2022)

Lipidomic signature of stroke recurrence after transient ischemic attack
por: Purroy, F., et al.
Publicado: (2023)

Differentiation of true transient ischemic attack versus transient ischemic attack mimics
por: Noureddine, Ali, et al.
Publicado: (2014)

Risk of Subsequent Events in Patients With Minor Ischemic Stroke or High-Risk Transient Ischemic Attack
por: Lee, Keon-Joo, et al.
Publicado: (2022)

Safety and efficacy of intensive vs. guideline antiplatelet therapy in high‐risk patients with recent ischemic stroke or transient ischemic attack: rationale and design of the Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke (TARDIS) trial (ISRCTN47823388)
Publicado: (2015)

Evaluating the Risk of Paroxysmal Atrial Fibrillation in Noncardioembolic Ischemic Stroke Using Artificial Intelligence-Enabled ECG Algorithm
por: Han, Changho, et al.
Publicado: (2022)

Antithrombotic Management of Patients with Nonvalvular Atrial Fibrillation and Ischemic Stroke or Transient Ischemic Attack: Executive Summary of the Korean Clinical Practice Guidelines for Stroke
por: Jung, Keun-Hwa, et al.
Publicado: (2015)

Patient perspectives on health‐related behavior change after transient ischemic attack or ischemic stroke
por: Brouwer‐Goossensen, Dorien, et al.
Publicado: (2021)

Impact of multiple cardiovascular medications on mortality after an incidence of ischemic stroke or transient ischemic attack
por: Ma, Tian-Tian, et al.
Publicado: (2021)

Minor Stroke and Transient Ischemic Attack: Research and Practice
por: Yakhkind, Aleksandra, et al.
Publicado: (2016)

Electrolytes and clinical outcomes in patients with acute ischemic stroke or transient ischemic attack
por: Wang, Anxin, et al.
Publicado: (2021)

Recurrent Stroke in Minor Ischemic Stroke or Transient Ischemic Attack With Metabolic Syndrome and/or Diabetes Mellitus
por: Chen, Weiqi, et al.
Publicado: (2017)

Creatine Kinase Is Associated With Recurrent Stroke and Functional Outcomes of Ischemic Stroke or Transient Ischemic Attack
por: Li, Shiyu, et al.
Publicado: (2022)

Camptocormia with Transient Ischemic Attack
por: Oh, Ju-Hee, et al.
Publicado: (2017)

Headache in transient ischemic attacks
por: Lebedeva, Elena R., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ffjv58n866ts50h2pi0k14tim3